JY
ASLN

Jeff Yass’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Jeff Yass’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,610
Closed -$399K – 14111
2021
Q3 		$399K Buy
+5,610
New +$638K ﹤0.01% 9950

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Jeff Yass's ASLN Position: Q1 2022 in Review

Jeff Yass sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2022, closing a stake of 470 shares — an estimated $21K sold.

Jeff Yass first reported a position in ASLN in Q4 2019 and held it in 5 quarters. The position peaked at $399K in Q3 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q1 2022.

  • Jeff Yass reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Jeff Yass sold 470 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2022, an estimated $21K.
  • Jeff Yass first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 5 quarters.
  • Jeff Yass's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $399K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.